{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:01:14Z","timestamp":1790082074745,"version":"4.0.1"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>There is considerable interest in the concept that psychedelic compounds might facilitate reorganization of emotional processing with therapeutic benefit; in particular, amelioration of excessive focus on past, current and potential-future aversive events, a dominant emotional-cognitive state in stress-related affective disorders. Translational animal models can advance understanding of specific aspects of this concept, namely, those relating to subconscious emotional memories and their neurobiology. In male mice, chronic social stress (CSS) leads to excessive tone\/context-foot shock Pavlovian aversion learning (PAL) and memory (PAM), measured as time spent in freezing behavior, and provides a model for generalized excessive focus on aversion. Sub-chronic administration of SSRI antidepressant between PAL and PAM reverses the excessive PAM of CSS mice. Here we applied the model to investigate acute and sustained behavioral and neurobiological effects of psilocybin (PSY) and ethocybin (ETH). In control male mice, both psychedelics at 3\u00a0mg\/kg per os resulted in 1\u20132\u00a0h of blood-brain exposure to the respective major metabolites psilocin and ethocin, and to head twitch responses. In the main experiment, mice underwent either 15-day CSS or control handling (CON), followed 2 days later by PAL, 1 day later by PSY, ETH or vehicle (VEH), and 3 days later by PAM testing and then brain collection. Relative to VEH, PSY and ETH led to increased PAM expression as more time spent in freezing behavior during tone\/context presentation. In a subset of these same mice, there was no psychedelic effect on densities of the two glutamatergic synaptic proteins investigated, vGluT1 or Homer1 in prelimbic cortex or amygdala. This study demonstrates that PSY and ETH lead to a sustained increase in aversive emotional memory expression in male mice. A similar effect in humans with stress- and trauma-related affective disorders might increase the psychotherapeutic accessibility of such memories.<\/jats:p>","DOI":"10.3389\/fphar.2026.1918182","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:07:29Z","timestamp":1790078849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice"],"prefix":"10.3389","volume":"17","author":[{"given":"David Ernst","family":"Hogg","sequence":"first","affiliation":[{"name":"Preclinical Laboratory, Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Romanos","sequence":"additional","affiliation":[{"name":"Preclinical Laboratory, Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Albiez","sequence":"additional","affiliation":[{"name":"Preclinical Laboratory, Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Hofer","sequence":"additional","affiliation":[{"name":"Preclinical Laboratory, Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wicki","sequence":"additional","affiliation":[{"name":"Preclinical Laboratory, Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]},{"name":"Zurich Neuroscience Center, University of Zurich and ETH Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali \u00d6zg\u00fcr","family":"Argun\u015fah","sequence":"additional","affiliation":[{"name":"Laboratory for Neural Circuit Assembly, Brain Research Institute, University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Sigrist","sequence":"additional","affiliation":[{"name":"Preclinical Laboratory, Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Thomann","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Basel","place":["Basel, Switzerland"]},{"name":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Luethi","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Basel","place":["Basel, Switzerland"]},{"name":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz X.","family":"Vollenweider","sequence":"additional","affiliation":[{"name":"Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Pryce","sequence":"additional","affiliation":[{"name":"Preclinical Laboratory, Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich","place":["Zurich, Switzerland"]},{"name":"Zurich Neuroscience Center, University of Zurich and ETH Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.bpsgos.2021.11.006","article-title":"Somatostatin receptor 4 agonism normalizes stress-related excessive amygdala glutamate release and Pavlovian aversion learning and memory in rodents","volume":"2","author":"Adamcyzk","year":"2022","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.9740\/mhc.2020.11.326","article-title":"Management of treatment-resistant generalized anxiety disorder","volume":"10","author":"Ansara","year":"2020","journal-title":"Ment. Health Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuropharm.2014.05.039","article-title":"Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function","volume":"85","author":"Azzinnari","year":"2014","journal-title":"Neuropharmacology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s44159-023-00156-1","article-title":"Understanding clinical fear and anxiety through the lens of human fear conditioning","volume":"2","author":"Beckers","year":"2023","journal-title":"Nat. Rev. Psychol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"107767","DOI":"10.1016\/j.neuropsychologia.2021.107767","article-title":"Amygdala-prefrontal connectivity during emotion regulation: a meta-analysis of psychophysiological interactions","volume":"153","author":"Berboth","year":"2021","journal-title":"Neuropsychologia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nn.4553","article-title":"Amygdala inputs to prefrontal cortex guide behavior amid conflicting cues of reward and punishment","volume":"20","author":"Burgos-Robles","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ibneur.2020.11.001","article-title":"Region- and receptor-specific effects of chronic social stress on the central serotonergic system in mice","volume":"10","author":"Carneiro-Nascimento","year":"2021","journal-title":"IBRO Neurosci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e12475","DOI":"10.1111\/gbb.12475","article-title":"Oligodendrocyte gene expression is reduced by and influences effects of chronic social stress in mice","volume":"18","author":"Cathomas","year":"2019","journal-title":"Genes, Brain Behav."},{"key":"B13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp. Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/02698811241286771","article-title":"Mechanisms of psilocybin on the treatment of posttraumatic stress disorder","volume":"40","author":"Choi","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"724606","DOI":"10.3389\/fpsyt.2021.724606","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"De Vos","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrn3027","article-title":"Neural mechanisms of the cognitive model of depression","volume":"12","author":"Disner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1097\/cm9.0000000000002647","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chin. Med. J. Engl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.neuron.2014.04.042","article-title":"Amygdala microcircuits controlling learned fear","volume":"82","author":"Duvarci","year":"2014","journal-title":"Neuron"},{"key":"B20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2015.12.020","article-title":"Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: both effects are reversed by inhibition of indoleamine 2 3-dioxygenase","volume":"54","author":"Fuertig","year":"2016","journal-title":"Brain, Behav. Immun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00213-019-05448-0","article-title":"Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment","volume":"238","author":"Godlewska","year":"2021","journal-title":"Psychopharmacol. Berl."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1017\/S0033291712000591","article-title":"Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients","volume":"42","author":"Godlewska","year":"2012","journal-title":"Psychol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nprot.2011.361","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat. Protoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","volume":"11","author":"Grunder","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ijnp\/pyab040","article-title":"A complex impact of systemically administered 5-HT2A receptor ligands on conditioned fear","volume":"24","author":"Hags\u00e4ter","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"PNAS"},{"key":"B29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cell.2011.10.009","article-title":"Molecular mechanisms of fear learning and memory","volume":"147","author":"Johansen","year":"2011","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0191225","DOI":"10.1371\/journal.pone.0191225","article-title":"Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice","volume":"13","author":"Just","year":"2018","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41386-023-01744-8","article-title":"Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala","volume":"49","author":"Kelly","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cpsp.12202","article-title":"Posttraumatic stress disorder: an integrated overview and neurobiological rationale for pharmacology","volume":"24","author":"Kelmendi","year":"2017","journal-title":"Clin. Psychol. (New York)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acsptsci.0c00176","article-title":"Investigation of the structure-activity relationships of psilocybin analogues","volume":"4","author":"Klein","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"17093","DOI":"10.1073\/pnas.1202087109","article-title":"Functional anatomy of neural circuits regulating fear and extinction","volume":"109","author":"Knapska","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"122486","DOI":"10.1016\/j.jchromb.2020.122486","article-title":"Development and validation of an LC-MS\/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma","volume":"1164","author":"Kolaczynska","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1210\/endo.133.5.8404687","article-title":"5'-Heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus","volume":"133","author":"Kwak","year":"1993","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1176\/appi.ajp.2016.16030353","article-title":"Using neuroscience to help understand fear and anxiety: a two-system framework","volume":"173","author":"Ledoux","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.psc.2024.02.006","article-title":"Psychedelics and evidence-based psychotherapy: a systematic review with recommendations for advancing psychedelic therapy research","volume":"47","author":"Leone","year":"2024","journal-title":"Psychiatr. Clin. North Am."},{"key":"B41","first-page":"175","article-title":"Hallucinogens as an aid in psychotherapy: basic principles and results","volume-title":"50 Years of LSD: Current Status and Perspectives of Hallucinogens. A Symposium the Swiss Academy of Medical Sciences","author":"Leuner","year":"1994"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.08.647810","article-title":"A multi-institutional investigation of psilocybin\u2019s effects on mouse behavior","author":"Lu","year":"2025","journal-title":"bioRxiv"},{"key":"B43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.neuint.2012.06.014","article-title":"Scaffold protein Homer 1: implications for neurological diseases","volume":"61","author":"Luo","year":"2012","journal-title":"Neurochem. Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/02698811251395386","article-title":"An exploration of the relationships between the effects of psilocybin on behavior, 5-HT(2A) receptor occupancy, and neuroplastic effects in mice","volume":"40","author":"Maltby","year":"2026","journal-title":"J. Psychopharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/7854_2017_480","article-title":"Interactions of hallucinogens with the glutamatergic system: permissive network effects mediated through cortical layer V pyramidal neurons","volume":"36","author":"Marek","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1038\/s41467-017-02367-6","article-title":"VGLUT1 functions as a glutamate\/proton exchanger with chloride channel activity in hippocampal glutamatergic synapses","volume":"8","author":"Martineau","year":"2017","journal-title":"Nat. Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cpt.557","article-title":"Psychedelics as medicines: an emerging new paradigm","volume":"101","author":"Nichols","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1020505","DOI":"10.3389\/fpsyt.2022.1020505","article-title":"Lower-dose psycholytic therapy - a neglected approach","volume":"13","author":"Passie","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B53","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"B54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000331595","article-title":"A 5-year longitudinal study of posttraumatic stress disorder in primary care patients","volume":"45","author":"Perez Benitez","year":"2012","journal-title":"Psychopathology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"110430","DOI":"10.1016\/j.neuropharm.2025.110430","article-title":"Chronic social stress induces generalized hyper-sensitivity to aversion: a mouse model with translational validity for understanding and treating negative valence disorders","volume":"273","author":"Poggi","year":"2025","journal-title":"Neuropharmacology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/bph.70305","article-title":"TRP canonical 4 and\/or 5 channel inhibition reduces aversion- and increases reward-responding in chronically stressed mice","volume":"183","author":"Poggi","year":"2026","journal-title":"Br. J. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","article-title":"The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation","volume":"27","author":"Preller","year":"2017","journal-title":"Curr. Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuropharm.2010.09.015","article-title":"Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL\/6 mice","volume":"60","author":"Pryce","year":"2011","journal-title":"Neuropharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","article-title":"In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents","volume":"13","author":"Puig","year":"2003","journal-title":"Cereb. Cortex"},{"key":"B60","doi-asserted-by":"publisher","first-page":"108195","DOI":"10.1016\/j.pharmthera.2022.108195","article-title":"Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation","volume":"239","author":"Raut","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1021\/acsptsci.5c00462","article-title":"Psilocybin enhances cued fear extinction and extinction recall in stress-naive, acutely stressed, and chronically stressed mice","volume":"8","author":"Razidlo","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.ne.11.030188.001553","article-title":"Behavioral studies of Pavlovian conditioning","volume":"11","author":"Rescorla","year":"1988","journal-title":"Annu. Rev. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41593-025-01964-9","article-title":"Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles","volume":"28","author":"Rogers","year":"2025","journal-title":"Nat. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiat"},{"key":"B66","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2165\/00023210-200923080-00001","article-title":"STAR*D: revising conventional wisdom","volume":"23","author":"Rush","year":"2009","journal-title":"CNS Drugs"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cereb. Cortex"},{"key":"B68","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/s0166-2236(00)01969-x","article-title":"Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective","volume":"24","author":"Schafe","year":"2001","journal-title":"Trends Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.neuron.2013.11.006","article-title":"Long-range connectivity defines behavioral specificity of amygdala neurons","volume":"81","author":"Senn","year":"2014","journal-title":"Neuron"},{"key":"B70","doi-asserted-by":"publisher","first-page":"14148","DOI":"10.3390\/ijms232214148","article-title":"Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head Twitch response induced by 5-Hydroxytryptophan and psilocybin: translational implications","volume":"23","author":"Shahar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"B72","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-025-08813-6","article-title":"Psilocybin's lasting action requires pyramidal cell types and 5-HT(2A) receptors","volume":"642","author":"Shao","year":"2025","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1021\/acs.jnatprod.9b01061","article-title":"Synthesis and biological evaluation of tryptamines found in hallucinogenic mushrooms: norbaeocystin, baeocystin, norpsilocin, and aeruginascin","volume":"83","author":"Sherwood","year":"2020","journal-title":"J. Nat. Prod."},{"key":"B74","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/npp.2010.184","article-title":"Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear","volume":"36","author":"Sierra-Mercado","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e1008","DOI":"10.1002\/cpz1.1008","article-title":"Mouse model of chronic social stress-induced excessive Pavlovian aversion learning-memory","volume":"4","author":"Sigrist","year":"2024","journal-title":"Curr. Protoc."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.tips.2025.08.012","article-title":"Emerging mechanisms of psilocybin-induced neuroplasticity","volume":"46","author":"Sonda","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1391689","DOI":"10.3389\/fphar.2024.1391689","article-title":"In vitro and in vivo metabolism of psilocybin's active metabolite psilocin","volume":"15","author":"Thomann","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"B80","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.eclinm.2022.101809","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"Von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.neuroscience.2006.08.003","article-title":"Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala","volume":"143","author":"Vyas","year":"2006","journal-title":"Neuroscience"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/da.23065","article-title":"Historic psychedelic drug trials and the treatment of anxiety disorders","volume":"37","author":"Weston","year":"2020","journal-title":"Depress. Anxiety"},{"key":"B83","doi-asserted-by":"publisher","first-page":"114864","DOI":"10.1016\/j.isci.2026.114864","article-title":"Development of visual-stimulus reversal learning-memory in mice is dependent on social interaction","volume":"29","author":"Wicki","year":"2026","journal-title":"iScience"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front. Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1021\/acschemneuro.4c00279","article-title":"Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors","volume":"15","author":"Woodburn","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"873279","DOI":"10.3389\/fpsyg.2022.873279","article-title":"Psychedelics and psychotherapy: cognitive-behavioral approaches as default","volume":"13","author":"Yaden","year":"2022","journal-title":"Front. Psychol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41380-020-00991-1","article-title":"Homer1 promotes dendritic spine growth through ankyrin-G and its loss reshapes the synaptic proteome","volume":"26","author":"Yoon","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jad.2023.04.105","article-title":"How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change","volume":"334","author":"Zeifman","year":"2023","journal-title":"J. Affect Disord."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1918182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:07:30Z","timestamp":1790078850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1918182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":88,"alternative-id":["10.3389\/fphar.2026.1918182"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1918182","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1918182"}}